25.07.2024 • NewsSyensqoCollaborationaerospace materials

Syensqo & Orbex to Collaborate on Next-Gen Space Launch Systems

Syensqo, a global provider of advanced materials, and Orbex, a leader in private space launch services, recently signed a strategic collaboration agreement to develop and deploy next-generation aerospace technologies.

Syensqo and Orbex will collaborate on the integration of Syensqo's advanced adhesive, composite and specialty polymer materials into Orbex's launch vehicles to drive advancements in the performance, durability and sustainability of orbital launch systems.

"We are thrilled to partner with Orbex, a company that shares our vision for innovation and sustainability in the aerospace sector," stated Marc Doyle, Business Executive Vice-President of Syensqo Composite Materials. "This agreement is more than just a collaboration; it's a commitment to pushing the boundaries of what's possible for space launch technology, and we are excited to contribute our advanced materials to Orbex's pioneering projects."

“At Orbex we want our suppliers to align with our company values of having a strong focus on quality and sustainability,” said Phil Chambers, CEO of Orbex. “Our partnership with Syensqo will enable us to develop one of the most advanced, low carbon, high performance micro-launch vehicles in the world, offering the small satellite industry flexible, dedicated launches, directly from the UK.”

Orbex launch vehicle. © Orbex
Orbex launch vehicle. © Orbex

This partnership will focus on furthering the adoption of advanced materials into the most challenging applications through a close technical collaboration involving support from Syensqo’s Heanor Application Center and extensive test lab capability. Applications include space launch systems, with a focus on weight reduction, thermal resistance, and enhanced structural integrity.

Company

Syensqo

rue de la Fusée 98
B-1130 Brussels
Belgium

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read